查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1605765

连续皮下胰岛素输注市场，按产品类型、患者类型、最终用途、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Continuous Subcutaneous Insulin Infusion Market, By Product Type, By Patient Type, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 388 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年，持续皮下胰岛素输注市场规模为42.45亿美元，2024年至2032年复合年增长率为9.89%。

连续皮下胰岛素输注市场-市场动态

人们对先进胰岛素输送设备的认识不断增强，以推动市场需求

持续皮下胰岛素输注 (CSII) 市场受到糖尿病发病率上升和对先进胰岛素输送意识增强的推动，目前 40% 的 1 型糖尿病患者使用胰岛素帮浦。然而，高昂的医疗成本和有限的可及性可能会阻碍该行业的成长。相反，机会在于人工智慧和物联网创新，这些创新可以增强泵浦功能和患者体验，同时人工胰臟系统的进步有望扩大资料整合并改善血糖控制。

连续皮下胰岛素输注市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 9.89% 左右的复合年增长率成长

根据产品类型细分，系留帮浦预计将在 2023 年呈现最大市场份额

根据患者类型细分，1型是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

连续皮下胰岛素输注市场-細項分析：

全球连续皮下胰岛素输注市场根据产品类型、患者类型、最终用途和地区进行细分。

市场依产品类型分为三类：贴片帮浦和繫留帮浦。系留泵领域主导市场。空气对空气热泵几乎不需要维护并且安装简单。选择它而不是地源热泵系统，因为没有基础工程成本且更具成本效益。

根据患者类型，市场分为两类：1 型和 2 型。这主要是由于它的可访问性和便携性，占据了重要的市场份额。这些设备可轻鬆佩戴在衣服内或外，为胰岛素管理提供便利。

连续皮下胰岛素输注市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。

连续皮下胰岛素输注市场-竞争格局：

全球市场的推动力是越来越多地采用先进的胰岛素管理解决方案，强调用户友好的技术和改进的血糖控制。市场策略包括加强设备与血糖监测系统整合的合作伙伴关係，为主动糖尿病管理提供即时资料和预测分析。此外，各公司正专注于开发紧凑、谨慎的胰岛素帮浦和可客製化的剂量选项，以满足特定患者的需求，特别是在管理不同人群的 1 型糖尿病方面。

目录

第一章：连续皮下胰岛素输注市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的连续皮下胰岛素输注市场片段
    • 按患者类型分類的连续皮下胰岛素输注市场片段
    • 以最终用途分類的连续皮下胰岛素输注市场片段
    • 按国家/地区分類的连续皮下胰岛素输注市场片段
    • 按地区分類的连续皮下胰岛素输注市场片段
  • 竞争洞察

第 3 章：持续皮下胰岛素输注主要市场趋势

  • 连续皮下胰岛素输注市场驱动因素
    • 市场驱动因素的影响分析
  • 连续皮下胰岛素输注市场限制
    • 市场限制影响分析
  • 持续皮下胰岛素输注市场机会
  • 连续皮下胰岛素输注市场未来趋势

第 4 章：连续皮下胰岛素输注产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：连续皮下胰岛素输注市场：地缘政治紧张局势升级的影响

  • COVID-19 大流行的影响
  • 俄罗斯-乌克兰战争的影响
  • 中东衝突的影响

第 6 章：连续皮下胰岛素输注市场格局

  • 2023 年连续皮下胰岛素输注市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：连续皮下胰岛素输注市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 贴片泵浦
      • 基础和推注
      • 基础
      • 丸
    • 繫留泵浦
      • 电池
      • 胰岛素套件插入装置
      • 胰岛素储存库和药筒

第 8 章：连续皮下胰岛素输注市场 - 依病患类型

  • 概述
    • 按患者类型分類的细分市场份额分析
    • 类型1
    • 2型

第 9 章：连续皮下胰岛素输注市场 - 依最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 实验室
    • 居家护理
    • 医院

第 10 章：连续皮下胰岛素输注市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美连续皮下胰岛素输注主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按患者类型）
    • 北美市场规模和预测（按最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲连续皮下胰岛素输注主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按患者类型）
    • 欧洲市场规模和预测（按最终用途）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区连续皮下胰岛素输注主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模和预测（按患者类型）
    • 亚太地区市场规模和预测（按最终用途）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲连续皮下胰岛素输注主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按患者类型）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲连续皮下胰岛素输注主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按患者类型）
    • 中东和非洲市场规模和预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析-连续皮下胰岛素输注产业

  • 竞争仪表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Medtronic Inc.
    • CeQur
    • Tandem Diabetes Care
    • F Hoffmann-La Roche
    • Ypsomed
    • Insulet Corporation
    • Sooil Development
    • Valeritas Inc.
    • Cellenovo
    • B. Braun Melsungen AG
    • Bigfoot Biomedical, Inc.
    • Becton, Dickinson and Company
    • Fresenius SE & Co. KGaA
    • MicroPort Scientific Corporation
    • MannKind Corporation
    • Nipro Corporation
    • Shinmyung Mediyes CO., LTD.
    • Sanofi SA
    • Smiths Group PLC
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4325

REPORT HIGHLIGHT

Continuous subcutaneous insulin infusion market size was valued at USD 4,245 Million in 2023, expanding at a CAGR of 9.89% from 2024 to 2032.

Continuous subcutaneous insulin infusion (CSII) is a diabetes management method that uses an insulin pump to deliver small, continuous doses of rapid-acting insulin under the skin. This method mimics the body's natural insulin release, which helps in maintaining stable blood glucose levels. Patients can adjust doses for meals or exercise, offering flexibility and better glycemic control. CSII is especially beneficial for individuals with type 1 diabetes who require precise insulin regulation throughout the day and night.

Continuous Subcutaneous Insulin Infusion Market- Market Dynamics

Growing awareness about advanced insulin delivery devices to propel market demand

The continuous subcutaneous insulin infusion (CSII) market is driven by rising diabetes rates and increased awareness of advanced insulin delivery, with 40% of type 1 diabetes patients currently using insulin pumps. However, high healthcare costs and limited accessibility may hamper the industry's growth. On the contrary, Opportunities lie in AI and IoT innovations that enhance pump functionality and patient experience, alongside the advancement of artificial pancreas systems which promise expanded data integration and improved glucose control.

Continuous Subcutaneous Insulin Infusion Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.89% over the forecast period (2024-2032)

Based on product type segmentation, tethered pump was predicted to show maximum market share in the year 2023

Based on patient type segmentation, type 1 was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Continuous Subcutaneous Insulin Infusion Market- Segmentation Analysis:

The Global Continuous Subcutaneous Insulin Infusion Market is segmented based on Product Type, Patient Type, End-use, and Region.

The market is divided into three categories based on product type: patch pumps and tethered pumps. The tethered pumps sector dominates the market. The air-to-air heat pump requires very little maintenance and is simple to install. It is chosen over ground source heat pump systems since there are no groundwork costs and it is more cost-effective.

The market is divided into two categories based on patient type: type 1 and type 2. The type 1 sector dominates the market and is likely to maintain its dominance during the forecast period. This is majorly due to its accessibility and portability, capturing a significant market share. These devices, easily worn under or outside clothing, offer convenience for insulin management.

Continuous Subcutaneous Insulin Infusion Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Continuous Subcutaneous Insulin Infusion Market- Competitive Landscape:

The global market is driven by the growing adoption of advanced insulin management solutions, emphasizing user-friendly technology and improved glycemic control. Market strategies include partnerships to enhance device integration with glucose monitoring systems, enabling real-time data and predictive analytics for proactive diabetes management. Additionally, companies are focusing on developing compact, discreet insulin pumps and customizable dosing options to cater to specific patient needs, particularly in managing type 1 diabetes across diverse demographics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic Inc.
  • CeQur
  • Tandem Diabetes Care
  • F Hoffmann-La Roche
  • Ypsomed
  • Insulet Corporation
  • Sooil Development
  • Valeritas Inc.
  • Cellenovo
  • B. Braun Melsungen AG
  • Bigfoot Biomedical, Inc.
  • Becton, Dickinson and Company
  • Fresenius SE & Co. KGaA
  • MicroPort Scientific Corporation
  • MannKind Corporation
  • Nipro Corporation
  • Shinmyung Mediyes CO., LTD.
  • Sanofi S.A.
  • Smiths Group PLC
  • Others

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Patch Pumps
  • Bolus
  • Basal
  • Basal & Bolus
  • Tethered Pumps
  • Battery
  • Insulin Set Insertion Devices
  • Insulin Reservoir & Cartridges

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Type 1
  • Type 2

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Laboratories
  • Homecare
  • Hospitals

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Continuous Subcutaneous Insulin Infusion Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Continuous Subcutaneous Insulin Infusion Market Snippet by Product Type
    • 2.1.2. Continuous Subcutaneous Insulin Infusion Market Snippet by Patient Type
    • 2.1.3. Continuous Subcutaneous Insulin Infusion Market Snippet by End-use
    • 2.1.4. Continuous Subcutaneous Insulin Infusion Market Snippet by Country
    • 2.1.5. Continuous Subcutaneous Insulin Infusion Market Snippet by Region
  • 2.2. Competitive Insights

3. Continuous Subcutaneous Insulin Infusion Key Market Trends

  • 3.1. Continuous Subcutaneous Insulin Infusion Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Continuous Subcutaneous Insulin Infusion Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Continuous Subcutaneous Insulin Infusion Market Opportunities
  • 3.4. Continuous Subcutaneous Insulin Infusion Market Future Trends

4. Continuous Subcutaneous Insulin Infusion Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Continuous Subcutaneous Insulin Infusion Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Continuous Subcutaneous Insulin Infusion Market Landscape

  • 6.1. Continuous Subcutaneous Insulin Infusion Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Continuous Subcutaneous Insulin Infusion Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Patch Pumps
      • 7.1.2.1. Basal & Bolus
      • 7.1.2.2. Basal
      • 7.1.2.3. Bolus
    • 7.1.3. Tethered Pumps
      • 7.1.3.1. Battery
      • 7.1.3.2. Insulin Set Insertion Devices
      • 7.1.3.3. Insulin Reservoir & Cartridges

8. Continuous Subcutaneous Insulin Infusion Market - By Patient Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Patient Type, 2023 & 2032 (%)
    • 8.1.2. Type 1
    • 8.1.3. Type 2

9. Continuous Subcutaneous Insulin Infusion Market - By End-use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-use, 2023 & 2032 (%)
    • 9.1.2. Laboratories
    • 9.1.3. Homecare
    • 9.1.4. Hospitals

10. Continuous Subcutaneous Insulin Infusion Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Continuous Subcutaneous Insulin Infusion Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Medtronic Inc.
    • 11.2.2. CeQur
    • 11.2.3. Tandem Diabetes Care
    • 11.2.4. F Hoffmann-La Roche
    • 11.2.5. Ypsomed
    • 11.2.6. Insulet Corporation
    • 11.2.7. Sooil Development
    • 11.2.8. Valeritas Inc.
    • 11.2.9. Cellenovo
    • 11.2.10. B. Braun Melsungen AG
    • 11.2.11. Bigfoot Biomedical, Inc.
    • 11.2.12. Becton, Dickinson and Company
    • 11.2.13. Fresenius SE & Co. KGaA
    • 11.2.14. MicroPort Scientific Corporation
    • 11.2.15. MannKind Corporation
    • 11.2.16. Nipro Corporation
    • 11.2.17. Shinmyung Mediyes CO., LTD.
    • 11.2.18. Sanofi S.A.
    • 11.2.19. Smiths Group PLC
    • 11.2.20. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us